News | September 26, 2013

ASRT Foundation and RAD-AID International To Launch Education

September 26, 2013 – The ASRT Foundation and RAD-AID International have announced plans to offer a program for radiation therapists to teach in China.

The program will provide radiation therapists with the opportunity to travel to China to lecture at specialty conferences, spearhead didactic teaching at medical facilities, participate in equipment demonstrations and develop case discussions. Lectures will cover a broad range of topics including practice techniques, quality control and patient safety.

“According to RAD-AID’s 2010 Radiology-Readiness Assessment, Chinese imaging professionals benefit from additional educational opportunities,” said ASRT Foundation board of trustees chair Parsha Hobson, M.P.A., R.T. “Through the radiation therapy teaching program, we’re confident that radiation therapy professionals in China will learn advanced skills that they can apply in the workplace, ultimately resulting in improved patient care.”

A minimum of two teams with expertise in imaging for radiation therapy planning and execution will be selected annually. For each team, the ASRT Foundation will provide funding for one board-certified radiation therapist to join a radiation oncologist or radiologist sponsored by RAD-AID International.

“RAD-AID’s partnership with the ASRT Foundation in offering this program is a cornerstone of our commitment to building interdisciplinary teams with diverse skill sets to foster international collaboration for global radiology and radiation therapy. This new program embodies our commitment to international education and strengthening collaboration among imaging professionals and radiation therapists,” said RAD-AID chief executive officer Daniel Mollura.  

The Foundation unveiled the new program at the ASRT Radiation Therapy Conference in Atlanta, Sept. 22-24. Interested individuals may apply using the R.T. Fellowship Program for Developing Countries application at www.asrtfoundation.org/opportunities

Related Content

University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
Accuray Radixact

Accuray Radixact

Feature | Radiation Therapy | May 29, 2019 | By Jeff Zagoudis
While radiation therapy as a disciplin
Sponsored Content | Case Study | Radiation Therapy | May 29, 2019
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at
Improved Imaging for Prostate Cancer Could Lead to More Effective Treatment

The picture shows that time series signal is extracted from a series of ultrasound frames for classification. Each patch across a number of frames inside the prostate is classified into either cancerous or normal tissue. The image at the lower right corner shows the overall result for those frames. Image courtesy of Pingkun Yan and researchers from NIH, University of British Columbia and Queens University.

News | Ultrasound Imaging | May 28, 2019
Engineers at Rensselaer Polytechnic Institute are working to improve imaging methods in order to make medicine more...
Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res